Innovations for GFN 2024
The Global Forum on Nicotine is set to build on previous triumphs with further innovations for the 2024 event and is setting itself up to be the best one yet
-
by Dave Cross
Share on:
The team says: “GFN24 will take place online and live in Warsaw from 13 - 15 June 2024. The 11th GFN conference will explore the theme of 'Economics, Health and Tobacco Harm Reduction’ and will feature expert-led discussion on the public health role of safer nicotine products and their economic impact.
“The GFN programme is always driven by the latest science and evidence, and we are very excited that ScienceLab will be building on this. The theme of economy extends to our prices, with #GFN24 registration fees frozen at 2023 levels.”
The action isn’t waiting until June, organisers add: “As if you needed any more inspiration! GFN•TV, the broadcast arm of the GFN stable, reports on the latest tobacco harm reduction policy and news, as well as highlighting some of the stories you might have missed. In recent weeks we’ve featured interviews with several leading lights in tobacco harm reduction, including #GFN23 Michael Russell Orator Roberto Sussman, who joined us to discuss Mexico’s tightening restrictions on safer nicotine products, GFN23 panellist Garrett McGovern, who explored Ireland’s latest regulatory changes, and GFN22 host Michelle Minton who joined us to shed a light on how coverage of the teen vaping ‘epidemic’ has amplified the public debate around vaping in the USA.”
What is the GFN Film Festival?
Filmmakers, creators, and advocates are being invited to submit work that highlights the importance of tobacco harm reduction as a key public health strategy.
They say: “Through the power of visual storytelling, we aim to raise awareness, educate, and inspire positive change in individuals and society concerning tobacco use and its associated risks.”
The submission can be in the form of a documentary, a narrative/short film, animation, public service announcement, or educational video.
“Submissions should be accurate, well-researched, and supported by credible sources. Any scientific or medical claims should be based on reliable evidence,” they say, adding, “Films must be in English or have English subtitles.”
What is the GFN ScienceLab?
GFNFives submitted in the ‘Science and research’ category will be eligible for inclusion in Science Lab and given 15 minutes to present and discuss their work.
#GFNFives are five minute videos, with formats including slideshow with voiceover, animation, or recorded presentations, which cover policy, legislative and regulatory issues, consumer advocacy, regional updates and more general information about tobacco harm reduction.
All GFNFives entries must be submitted by 15 May 2024.
References:
- The Global Forum on Nicotine - https://gfn.events/
Dave Cross
Journalist at POTVDave is a freelance writer; with articles on music, motorbikes, football, pop-science, vaping and tobacco harm reduction in Sounds, Melody Maker, UBG, AWoL, Bike, When Saturday Comes, Vape News Magazine, and syndicated across the Johnston Press group. He was published in an anthology of “Greatest Football Writing”, but still believes this was a mistake. Dave contributes sketches to comedy shows and used to co-host a radio sketch show. He’s worked with numerous vape companies to develop content for their websites.
Join the discussion
Harm Reduction For The Rich
The United Kingdom risks becoming a harm reduction country only for the wealthy, according to Michael Landl of the World Vapers’ Alliance
-
by Dave Cross
CAPHRA Highlights Tobacco Control Flaws
The Coalition of Asia Pacific Tobacco Harm Reduction Advocates highlights the flaws in tobacco control which has led to the rise of black market in Australia
-
by Dave Cross
A Missed Opportunity at COP10
The Smoke Free Sweden movement says that COP10 was a missed opportunity to save millions of lives
-
by Dave Cross
COP10: Promote Tobacco Harm Reduction
Experts with Smoke Free Sweden are emphasising the urgent need for a Tobacco Harm Reduction approach at COP10
-
by Dave Cross
